(Q52942846)

English

PI3-K/AKT/FKHR and MAPK signaling cascades are redundantly stimulated by a variety of cytokines and contribute independently to proliferation and survival of multiple myeloma cells.

scientific article published in November 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/15356648

PI3-K/AKT/FKHR and MAPK signaling cascades are redundantly stimulated by a variety of cytokines and contribute independently to proliferation and survival of multiple myeloma cells. (English)

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/15356648

multiple myeloma

1 reference

based on heuristic

inferred from title

author name string

S Lentzsch

1

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/15356648

M Chatterjee

2

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/15356648

M Gries

3

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/15356648

K Bommert

4

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/15356648

H Gollasch

5

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/15356648

B Dörken

6

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/15356648

R C Bargou

7

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/15356648

publication date

1 November 2004

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/15356648

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/15356648

18

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/15356648

1883-1890

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/15356648

11

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/15356648

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403486

0 references

Interleukin 6 is essential for in vivo development of B lineage neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403486

21 January 2018

Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403486

21 January 2018

Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403486

21 January 2018

Role of the AKT kinase in expansion of multiple myeloma clones: effects on cytokine-dependent proliferative and survival responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403486

21 January 2018

Chimaeric anti-interleukin 6 monoclonal antibodies in the treatment of advanced multiple myeloma: a phase I dose-escalating study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403486

21 January 2018

In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp130/STAT3 pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403486

21 January 2018

Macrophage inflammatory protein 1-alpha (MIP-1 alpha ) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403486

21 January 2018

Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-mediated multiple myeloma cell adhesion to CS-1/fibronectin and VCAM-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403486

21 January 2018

Effects of interleukin-3 and interleukin-6 on peripheral blood cells from multiple myeloma patients and their clinical significance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403486

21 January 2018

The IL-6 receptor antagonist SANT-7 overcomes bone marrow stromal cell-mediated drug resistance of multiple myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403486

21 January 2018

Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403486

21 January 2018

Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403486

21 January 2018

Antisense inhibition of macrophage inflammatory protein 1-alpha blocks bone destruction in a model of myeloma bone disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403486

21 January 2018

Didox (a novel ribonucleotide reductase inhibitor) overcomes Bcl-2 mediated radiation resistance in prostate cancer cell line PC-3.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403486

21 January 2018

C-kit ligand (SCF) in human multiple myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403486

21 January 2018

IL-3 expression by myeloma cells increases both osteoclast formation and growth of myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403486

21 January 2018

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403486

21 January 2018

Interleukin-15 blocks apoptosis and induces proliferation of the human myeloma cell line OH-2 and freshly isolated myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403486

21 January 2018

Interleukin-21 is a growth and survival factor for human myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403486

21 January 2018

Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403486

21 January 2018

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403486

21 January 2018

AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403486

21 January 2018

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403486

21 January 2018

Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403486

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403486

7 January 2021

based on heuristic

inferred from DOI database lookup

Syndecan-1 expression on malignant cells from the blood and marrow of patients with plasma cell proliferative disorders and B-cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403486

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential expression of chemokine receptors in B cell malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403486

7 January 2021

based on heuristic

inferred from DOI database lookup

IL-1beta expression in IgM monoclonal gammopathy and its relationship to multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403486

7 January 2021

based on heuristic

inferred from DOI database lookup

The gp 130 family cytokines IL-6, LIF and OSM but not IL-11 can reverse the anti-proliferative effect of dexamethasone on human myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403486

7 January 2021

based on heuristic

inferred from DOI database lookup

An activated mutant of R-Ras inhibits cell death caused by cytokine deprivation in BaF3 cells in the presence of IGF-I

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403486

7 January 2021

based on heuristic

inferred from DOI database lookup

Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403486

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2403486

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/15356648

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/15356648

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52942846&oldid=1522554089"